Mental Health Posters Archives - Page 4 of 5

Real-world outcomes among veterans severely affected by schizophrenia that transitioned from oral risperidone or paliperidone to once-monthly paliperidone palmitate

by [email protected] | Mar 27, 2019 | Mental Health Posters, Presentations

For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAmerican...

Economic burden of illness among US veterans with treatment-resistant depression

by [email protected] | Oct 25, 2018 | Mental Health Posters

For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAmerican...

Outcomes related to transition to once-every-three-monthly paliperidone palmitate among veterans with schizophrenia

by [email protected] | Oct 25, 2018 | Mental Health Posters

For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAmerican...

An evaluation of increased clinical and economic burden among elderly Medicare-covered beneficiaries with treatment-resistant depression

by [email protected] | Apr 23, 2018 | Mental Health Posters

…

Real-world comparison of treatment patterns, health care resource utilization and costs in schizophrenia patients treated with LAI vs oral antipsychotics: A real-world study

by [email protected] | Oct 16, 2017 | Mental Health Posters, Presentations

Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2017, Dallas, TX: Oct 16-19, 2017 For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select...

Burden of schizophrenia in recently diagnosed adult patients: A commercial payer perspective

by [email protected] | Sep 16, 2017 | Mental Health Posters

For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAmerican...

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Real-world outcomes among veterans severely affected by schizophrenia that transitioned from oral risperidone or paliperidone to once-monthly paliperidone palmitate

Economic burden of illness among US veterans with treatment-resistant depression

Outcomes related to transition to once-every-three-monthly paliperidone palmitate among veterans with schizophrenia

An evaluation of increased clinical and economic burden among elderly Medicare-covered beneficiaries with treatment-resistant depression

Real-world comparison of treatment patterns, health care resource utilization and costs in schizophrenia patients treated with LAI vs oral antipsychotics: A real-world study

Burden of schizophrenia in recently diagnosed adult patients: A commercial payer perspective

Subscribe to Our Blog